Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05595629 · ClinicalTrials.gov registry record · NA
App-based Remote Blood Pressure Monitoring
A NA study of Preeclampsia and Gestational Hypertension, sponsored by Women and Infants Hospital of Rhode Island.
- Completed
- Registry status
- NA
- Development phase
- 120
- Enrollment target
- 1
- Study location
NCT05595629 is a NA study of Preeclampsia and Gestational Hypertension that has completed, run by Women and Infants Hospital of Rhode Island. The registered enrollment target is 120 participants, below the 1,279-participant average among 39 other Preeclampsia trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05595629, a NA study of Preeclampsia and Gestational Hypertension, has completed, sponsored by Women and Infants Hospital of Rhode Island.
- COMPLETED
- Registry status
- NA
- Development phase
- 120 participants
- Enrollment target
- 1
- Study location
Study Summary
Remote postpartum blood pressure monitoring program with text messages has been shown to increase adherence to recommended postpartum blood pressure checks among those with hypertension at discharge from birth hospitalization, but these programs require medically trained professionals to respond to each individual text message. A bluetooth-enabled blood pressure cuff that synchs automatically a smartphone application that leverages Artificial Intelligence to provide tailored recommendations based on recorded blood pressure measurements--and can also provide on-demand education on hypertension--may be less costly way to provide similar support.
Conditions Studied
Interventions
- BEHAVIORAL App-based remote blood pressure monitoring
- BEHAVIORAL text-message based remote blood pressure monitoring
Study Locations (1)
Rhode Island
- Women & Infants Hospital of Rhode Island - Providence
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2022-11-07 |
| Est. Completion | 2023-08-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05595629
The ClinicalTrials.gov registry entry for NCT05595629 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,279-participant average among 39 other Preeclampsia trials with a reported enrollment target (91% lower). The listed sponsor is Women and Infants Hospital of Rhode Island, which has 65 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Preeclampsia appearing as the primary indexed condition, and to 2 interventions - of which App-based remote blood pressure monitoring is the first listed.
NCT05595629 reports 1 study location spanning 1 distinct geographic area - top geographies include Rhode Island.
Frequently Asked Questions
What is clinical trial NCT05595629 about?
NCT05595629 is a clinical study titled "App-based Remote Blood Pressure Monitoring". Remote postpartum blood pressure monitoring program with text messages has been shown to increase adherence to recommended postpartum blood pressure checks among those with hypertension at discharge from birth hospitalization, but these programs require medically trained professionals to respond to ...
What is the current status of trial NCT05595629?
This trial is currently completed. It is a NA study. The enrollment target is 120 participants. The study started on 2022-11-07. Estimated completion is 2023-08-30.
What conditions does trial NCT05595629 study?
This clinical trial studies the following conditions: Preeclampsia, Gestational Hypertension, Chronic Hypertension Complicating Pregnancy.
What interventions are being tested in trial NCT05595629?
The interventions under investigation include: App-based remote blood pressure monitoring (BEHAVIORAL), text-message based remote blood pressure monitoring (BEHAVIORAL).
Who is sponsoring clinical trial NCT05595629?
This trial is sponsored by Women and Infants Hospital of Rhode Island, which has 65 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05595629 being conducted?
This trial has 1 study location across Rhode Island. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Preeclampsia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Eliminating Severe Maternal Morbidity With Heart Health Doulas Trial
RECRUITING · NA
-
Optimizing Cardiovascular Preventive Care for Women Following Hypertensive Disorders of Pregnancy
RECRUITING · NA
-
The ACHIEVE Trial: Achieving Longer Gestation in Preeclampsia Via Antihypertensive Therapy.
RECRUITING · NA
-
Preventing Obstetric Complications With Dietary Intervention
RECRUITING · NA
-
Continuous Positive Airway Pressure (CPAP) for Sleep Apnea in Pregnancy
RECRUITING · NA
-
Preeclampsia Educational Program Study (PrEPS)
ACTIVE NOT RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.